LIVER FIBROSIS STUDIES

Within liver fibrosis studies we have:

​

The Fibroscan is a study that is used to measure the amount of fibrosis that forms in the liver caused by chronic inflammation of diseases that affect this organ such as hepatitis due to  alcohol o_cc781905-5cde-3194-bb3b -136bad5cf58d_virus C and/or B, steatohepatitis, biliary cirrhosis, etc.

This measurement is very important since it allows determining the degree of chronic damage (manifested by fibrosis), the success of the treatment administered (decrease or disappearance of fibrosis) and gives us a prognosis of the problem.

The Fibroscan, contrary to the liver biopsy, is a non-invasive, innocuous and painless study that gives us the same or more information than the biopsy.

Fasting is not required, is performed much like an abdominal ultrasound, and takes 10 to 15 minutes.

​

The Esteastoscan is a study used to measure the amount of fat inside the liver, which in most cases is caused by obesity, cholesterol, triglycerides, diabetes mellitus, arterial hypertension, uric acid and alcohol.

The importance of an early diagnosis is to avoid the accumulation of fat in the liver, since it can cause chronic inflammation – steatohepatitis – with the possibility of progression to fibrosis and cirrhosis. This measurement is very important since it allows determining the percentage of fat and liver damage to adjust the best treatment, periodic monitoring with this method gives us a prognosis of the issue.

The Steatoscan is a non-invasive, innocuous and painless study that gives us the same or more information than the biopsy. 

Fasting is not required, is performed much like an abdominal ultrasound, and takes 10 to 15 minutes.